TrialDiabetes & metabolism journal2022

Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study.

Hae Jin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.